Month: March 2017
-
Simpler Method Devised to Produce Malaria Drug
A biochemistry group in the U.K. developed simpler and potentially more efficient techniques for producing a first-line drug for treating malaria.
-
Medical Robotics Company Crowdfunding IPO
A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million.
-
Software Aims to Boost Lab Results Reproducibility
A software package that claims to tackle a growing problem of the failure to reproduce results of scientific research, is being field tested in an academic lab.
-
Allergan to Option Gene Editing for Eye Diseases
International drug maker Allergan is gaining access to treatments for inherited eye diseases being developed by Editas Medicine, a spin-off enterprise from MIT and Harvard.
-
Mobile App Shown Feasible for Asthma Data
An academic-industry team found a smartphone app can reliably collect data from people with asthma about their conditions, but some limitations remain.
-
Report: More Biotech Regulations Needed, and Soon
A new report from the National Academies calls for a more robust and responsive regulatory system to handle an anticipated flood of biotechnology products.
-
Univ. Spin-Off Develops Head Impact Sports Sensor
Two chemistry faculty in Michigan developed a simple sensor that measures the force and shows the location of head impacts in contact sports, and started a company to develop the product.
-
Inexpensive Pumps Devised for Portable Labs-on-Chips
An engineering lab developed an inexpensive pump without electric power for lab-on-a-chip devices, making these systems more portable for diagnostics.
-
Trial Shows Bioactive Glass Stops Bone Infections
Grafts of glass-based substitute material were shown in a clinical trial to stop bacterial bone infections from osteomyelitis, in most cases without additional antibiotics.
-
Nanotech Gel Designed to Treat Snake Bites
A team from University of California in Irvine developed a snake bite treatment that in lab tests stops venom more effectively and at lower cost than current antidotes.